Members of the community are invited to the Great Lakes Breast Cancer Symposium—hosted virtually by the Case Comprehensive Cancer Center—Oct. 25–26. This annual symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their work with the goal of developing cross-institutional collaborations.
Program topics covered will include:
- Therapeutics-response resistance;
- Survivorship and disparities;
- Cancer cell biology; and
- Microenvironment and immunology.
Keynote speaker Helen Piwnica-Worms, from the University of Texas MD Anderson Cancer Center, will present on “Tackling Resistance in Triple-negative Breast Cancer.”
Abstracts are invited on ongoing basic, translational, clinical and population breast cancer-focused research. Abstract submissions must be received by 5 p.m. ET, Friday, Aug. 6. Submissions will be used to identify additional speakers for the symposium.
Though this event is happening virtually, attendees will experience the conference using Whova, a web-based conference app, to view presentations and ask questions in real-time, as well as network with others behind the scenes.
Registration is $25 and will include continuing education credits and use of the official conference app.
The Great Lakes Breast Cancer Symposium is made possible through the collaboration of the Case Comprehensive Cancer Center, Ohio State University Comprehensive Cancer Center (The James), the UPMC Hillman Cancer Center affiliated with the University of Pittsburgh Schools of the Health Sciences and the WVU Cancer Institute at West Virginia University.